International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy

…, C Gachet, KA Jacobson, GA Weisman - Pharmacological …, 2006 - ASPET
There have been many advances in our knowledge about different aspects of P2Y receptor
signaling since the last review published by our International Union of Pharmacology …

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

TJ Wadas, EH Wong, GR Weisman… - Chemical …, 2010 - ACS Publications
Molecular imaging is the visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems. Molecular …

New therapies for treatment of rheumatoid arthritis

JS Smolen, D Aletaha, M Koeller, MH Weisman… - The lancet, 2007 - thelancet.com
Rheumatoid arthritis is characterised by pain, swelling, and destruction of joints, with
resultant disability. Only disease-modifying antirheumatic drugs can interfere with the disease …

Efficacy and safety of lebrikizumab in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis: a randomized …

…, P Rich, B Torkan, DF Fivenson, JD Weisman… - JAMA …, 2023 - jamanetwork.com
Importance Lebrikizumab (LEB), a high-affinity monoclonal antibody targeting interleukin (IL)-13,
demonstrated efficacy and safety in patients with moderate-to-severe atopic dermatitis (…

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the …

…, DE Furst, LW Moreland, MH Weisman… - Arthritis & …, 2003 - Wiley Online Library
Objective To evaluate the efficacy and safety of adalimumab (D2E7), a fully human monoclonal
tumor necrosis factor α antibody, in combination with methotrexate (MTX) in patients with …

The PREMIER study: a multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or …

FC Breedveld, MH Weisman… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To compare the efficacy and safety of adalimumab plus methotrexate (MTX)
versus MTX monotherapy or adalimumab monotherapy in patients with early, aggressive …

[HTML][HTML] Infliximab and methotrexate in the treatment of rheumatoid arthritis

…, JR Kalden, JS Smolen, M Weisman… - … England Journal of …, 2000 - Mass Medical Soc
Background Neutralization of tumor necrosis factor α (TNF-α) for three to six months reduces
the symptoms and signs of rheumatoid arthritis. However, the capacity of this approach to …

Band gap fluorescence from individual single-walled carbon nanotubes

…, WH Noon, C Kittrell, J Ma, RH Hauge, RB Weisman… - Science, 2002 - science.org
Fluorescence has been observed directly across the band gap of semiconducting carbon
nanotubes. We obtained individual nanotubes, each encased in a cylindrical micelle, by …

Structure-assigned optical spectra of single-walled carbon nanotubes

…, C Kittrell, RH Hauge, RE Smalley, RB Weisman - science, 2002 - science.org
Spectrofluorimetric measurements on single-walled carbon nanotubes (SWNTs) isolated in
aqueous surfactant suspensions have revealed distinct electronic absorption and emission …

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a …

…, F Breedveld, D Furst, J Kalden, M Weisman… - The Lancet, 1999 - thelancet.com
Background Not all patients with rheumatoid arthritis can tolerate or respond to methotrexate,
a standard treatment for this disease. There is evidence that antitumour necrosis factor α (…